Retrovirology announces new editorial board members and reprises progress over the first two years of publishing.
The reasons for Open Access
Undeniably, retrovirus researchers are well-served by several established subscription-based journals. However, on the current scientific landscape, there is a choice between two different ways of publishing research: the traditional journal (where subscribers and sometimes authors pay) and the Open Access model (where authors pay). The Open Access model embraces a novel concept that authors (or the funders of their research) pay for the submission and publication of papers. Once published, Open Access articles are free in full text to all interested readers. This means that your scientific colleague in Albania, the aspiring graduate student in Kenya, the young doctor in Chile, and the next James Watson or Alexander Fleming from Vietnam can all have unfettered, fee-free, full access to your Open Access article. Why would you want it any other way?
I have a personal reason for supporting Open Access. I am the 1 in 10 Americans born not in the United States but overseas in a developing country. Thirty-five years ago, my father was repeatedly rebuffed in his attempts to secure a visa to enter the United States to study at a graduate school. Had he not persevered, I might today be a frustrated scientist in a developing country unable to pay the subscription fees needed to read papers published in Nature, Cell or Virology. As science and societies move increasingly toward globalization, I am convinced that we all have a responsibility to work towards a knowledge access model that transcends professional classifications, national boundaries, and accidents of birth. As an American, I am confronted by the stark realization that in the just passed year, 2005, 47% of the US national debt was held by foreigners (a large portion by developing nations), and that the American economy stays afloat from an annual inflow of $216 billion from emerging markets (Barron's, March 26, 2006). Hence, should it not be viewed as simple fair reciprocity that American scientists support Open Access as a small gesture of give-back to the rest of the world?
Retrovirology's progress
Having stated the above, I don't believe that it is just altruism which should guide authors to support Open Access. A recently published study in PLOS Biology [1] showed the tangible benefit of Open Access publishing. That study clearly documented Open Access papers to be cited more quickly and more frequently than non-Open Access papers published in the same journal. Hence, it is perhaps not surprising that some long standing traditionally subscription-based journals such as Nucleic Acids Research and Journal of Clinical Investigation have adopted the completely Open Access model as their new way of publishing.
Retrovirology's experience is consistent with the recent report [1] . First, Retrovirology's Open Access format unquestionably attracts an impressively large readership. For instance, the Journal of Molecular Biology, a leading subscription journal, advertises as having been downloaded "nearly 750,000" times in a single year (2002) . Retrovirology is a much smaller journal with perhaps 20 times fewer published articles each year; and yet, Retrovirology is accessed an average of 1,700 times a day or over 600,000 times a year. I attribute this popularity to our Open Access(ibility). Second, we see a good correlation between the number of times that an article is read and the frequency that it is cited in the literature. This has been verified by access statistics from several of Retrovirology's already frequently cited papers (Fig. 1) [2] [3] [4] [5] [6] [7] . Finally, my impression is that Open Access has helped Retrovirology achieve rapid name recognition and a respectable preliminary Impact Factor number of nearly 3 (i.e. 2.98) just after our very first year of publishing. Retrovirology's current impact factor compares very favorably with those of Virology and Journal of General Virology (Fig. 2 ).
An impact factor of 3 at age 2 is a good start for Retrovirology. Nonetheless, I remain eager to receive your input as to how Retrovirology can further improve and do better.
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